We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
+9.48%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$836M
AUM Growth
+$4.91M
Cap. Flow
-$16.6M
Cap. Flow %
-1.98%
Top 10 Hldgs %
38.74%
Holding
112
New
6
Increased
28
Reduced
28
Closed
20

Sector Composition

Rank Sector Weight
1 Healthcare 85.37%
2 Industrials 2.83%
3 Technology 2.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UHS icon
101
Universal Health Services
UHS
$10.1B
-2,881
Closed -$385K
UNH icon
102
UnitedHealth
UNH
$391B
-34,488
Closed -$8.53M
KA
103
DELISTED
Kineta, Inc. Common Stock
KA
-14,645
Closed -$2.58M
IMGN
104
DELISTED
Immunogen Inc
IMGN
-58,013
Closed -$157K
QTNT
105
DELISTED
Quotient Limited Ordinary Shares
QTNT
-441
Closed -$159K
ADMS
106
DELISTED
Adamas Pharmaceuticals
ADMS
-808,924
Closed -$5.75M
DERM
107
DELISTED
Dermira, Inc.
DERM
-41,902
Closed -$568K
WCG
108
DELISTED
Wellcare Health Plans, Inc.
WCG
-16,251
Closed -$4.38M
ONCE
109
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
-3,554
Closed -$405K
NITE
110
DELISTED
Nightstar Therapeutics plc American Depositary Shares
NITE
-233,711
Closed -$5.93M
CELG
111
DELISTED
Celgene Corp
CELG
-179,700
Closed -$17M
BHVN
112
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
-3,900
Closed -$201K

Similar funds

Sectoral Asset Management's Q2 2019 Portfolio in Review

As of Q2 2019, Sectoral Asset Management held 112 positions worth $836M, up 0.59% from $831M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Sectoral Asset Management's Q2 2019 filing shows 6 new, 28 increased, 28 reduced and 20 closed positions. Its largest new stake was Alexion Pharmaceuticals: 73,199 shares worth $9.59M. The largest sale was Celgene Corp, an estimated $17M.

By sector, the portfolio is most concentrated in Healthcare at 85% of assets, up from 85% a quarter earlier, followed by Industrials and Technology.

  • Sectoral Asset Management's largest Q2 2019 buy was Alexion Pharmaceuticals: 73,199 shares worth $9.59M.
  • Sectoral Asset Management added most to Tandem Diabetes Care in Q2 2019, an estimated $11.9M increase.
  • Sectoral Asset Management's biggest Q2 2019 reduction was Insulet, cutting an estimated $5.61M.
  • Sectoral Asset Management fully exited Celgene Corp in Q2 2019, selling an estimated $17M.
  • Sectoral Asset Management's ten largest holdings make up 39% of its $836M portfolio in Q2 2019.
  • Sectoral Asset Management opened 6 new positions and closed 20 in Q2 2019.
  • Sectoral Asset Management's portfolio value rose 0.59% quarter-over-quarter to $836M.

Based on Sectoral Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.